MALVERN, PA — Trice Medical announced nationwide commercial availability of its FDA-cleared Tenex 2nd Generation System, an updated platform designed to expand minimally invasive treatment options for chronic tendon and musculoskeletal conditions, the company said.
The system builds on the Tenex Health TX platform, which has been used in more than 240,000 procedures since its introduction in 2012.
Trice Medical said the new system is designed to treat conditions including chronic tendon disease, calcific deposits, bone spurs and diabetic foot ulcers using ultrasonic technology.
The Tenex 2nd Generation System includes two longer ultrasonic handpieces, known as MicroTips, which allow physicians to access deeper anatomical areas such as the shoulder and hip.
The system also features updated power settings and expanded aspiration and irrigation controls through a redesigned console, according to the company.
The company said the new version follows a limited-use release phase and incorporates feedback from physicians and patients.
“This 2nd Generation device will allow us to further move the field of ultrasound guided surgery forward with more efficient treatment and expanded applications,” said Dr. Mederic M. Hall, a sports medicine physician at the University of Iowa Health Care.
Trice Medical said the original Tenex system established a minimally invasive approach that allows physicians to treat tendon-related conditions earlier, particularly when conservative treatments have not been effective.
The company, which operates in Malvern, Pennsylvania, and Lake Forest, California, develops minimally invasive medical technologies used in procedure rooms, ambulatory surgery centers and hospitals.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.